Daily electronic patient-reported outcome assessments may provide valuable insight into symptom management among patients with cancer undergoing antineoplastic treatment, according to a study published in JAMA Network Open.
Additionally, symptom alerts the assessments generated appeared associated with risk for acute care.
“The optimal cadence or ‘dosage’ of ePROs [electronic patient-reported outcomes] is an open question in cancer care. However, the cadence will likely vary based on the cohort of patients and where they are in their treatment trajectory,” Bobby Daly,